Globally, sepsis is a leading cause of death in children under 5. This unacceptable and preventable health crisis is worsened by drug resistance. Up to 40% of bacterial infections in newborns are resistant to standard treatments and more than 214,000 babies die each year from resistant infections. It is time to put children first in the fight against antibiotic resistance.
This webinar explored the threat of antibiotic resistance for children under 5, the unique challenges of antibiotic research and development for newborns, and the remarkable progress being made to reach Sustainable Development Goal 3 and ensure every child can survive and thrive.
- Christina Obiero, Co-investigator for GARDP fosfomycin clinical trial in Kilifi, Kenya
- Manica Balasegaram, Executive Director, GARDP
- Hanan Balkhy, Assistant Director-General for Antimicrobial resistance, WHO
- Stefan Peterson, Chief of Health, UNICEF
Moderator: Claire Doole
This webinar including Q&A session was broadcast on 25 June 2020.